← Open Payments lookup

YOUNG KIM: Open Payments

NPI 1417732546 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,916 in 79 payments from 16 companies in 2025. Trend: 2023 $177 · 2024 $1,170 · 2025 $1,916

Food & beverage: $1,916
CompanyPaymentsAmount
ABBVIE INC.26$430
Madrigal Pharmaceuticals6$375
Salix Pharmaceuticals, a division of Bausch Health US, LLC11$252
Janssen Biotech, Inc.5$217
Takeda Pharmaceuticals U.S.A., Inc.7$148
PFIZER INC.6$113
GENZYME CORPORATION4$109
Regeneron Healthcare Solutions, Inc.4$82
Alnylam Pharmaceuticals Inc.2$35
Invivyd Inc1$33

Products named: REZDIFFRA, TREMFYA, XIFAXAN, DUPIXENT, RINVOQ, ENTYVIO, LINZESS, SKYRIZI.

Industry payments across MD — which companies pay providers there.